part 6 - immune related adverse events with pdl1 and ctla4 inhibitors - dr. raya leibowitz, israel
Published 4 years ago • 30 plays • Length 22:28Download video MP4
Download video MP3
Similar videos
-
0:40
the impact of immune checkpoint inhibitor-related adverse events and their immunosupp... | rtcl.tv
-
2:45
correlation between cutaneous immune-related adverse events and os with immune checkpoint inhibitors
-
0:46
immune checkpoint inhibitors: recent progress and potential biomarkers - 3i pd-l1 overexpression
-
1:33
sitc clinical practice guidelines on immune checkpoint inhibitor-related adverse events
-
1:36
immunotherapy for nsclc | immune checkpoint inhibitors | ctla-4 inhibitors |
-
0:56
immune checkpoint inhibitors: recent progress and potential biomarkers - 1iv introduction
-
19:42
the ldl receptor part 6
-
2:27
do you order pd-l1 testing before choosing an immune checkpoint inhibitor?
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
1:04
dr. lee on trial data evaluating the atezolizumab/bevacizumab in unresectable hcc
-
1:57
managing the adverse events of immune checkpoint inhibitors
-
2:25
pre-clinical activity of ucartcs1 in multiple myeloma
-
3:54
neurological adverse events associated with immune checkpoint inhibitors
-
2:55
do clinical characteristics alter your enthusiasm for immune checkpoint inhibitors?
-
3:31
inhibiting cancer cell migration - israel vlodavsky technion
-
1:50
immune checkpoint inhibitors
-
5:03
tumour immunology and immunotherapy
-
0:46
immune checkpoint inhibitors: recent progress and potential biomarkers - 3iv pd-l1 overexpression